• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Panchsheel Organics Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 7121.0
  • ISIN : INE316G01019
122.35 1 (0.74%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    118.00

  • Today’s High

    125.95

  • Open

    125.95

  • Perv Close

    121.45

  • 52W Low

    86.10

  • 52W High

    175.60

Key Indicators

  • P/E(TTM)

    14.88

  • Mar.Cap (₹Cr.)

    161.16

  • Div & Yield %

    0.65

  • Book Value(₹)

    106.92

  • Debt-Equity Ratio

    0.74

  • AGM Date

    14-Aug-2026

  • EPS

    8.22

  • P/E Ratio

    14.88

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    161.16

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.17

  • BV (₹)

    106.90

  • Sales( ₹ in Cr.)

    106.78

  • NP (in Cr.)

    10.83

  • NP Var(%)

    -22.0

  • Div%

    8.0

  • CPS (₹)

    10.00

  • EPS (₹)

    8.20

  • Traded Value (₹ in Lakhs)

    161.16

  • 52 Week High

    175.60

  • 52 Week Low

    86.10

  • Price BSE

    122.0

  • Price NSE

    15.00

  • Market Capital( in Cr.)

    161.16

  • P/C Ratio

    12.20

  • P/E Ratio

    14.80

  • Price Vs.BV

    8.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 107.18 105.22 103.18 69.03 49.49 50.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 107.18 105.22 103.18 69.03 49.49 50.50
Other Income 3.07 2.46 1.18 0.09 0.18 0.19
Stock Adjustments 6.22 0.59 1.27 3.55 3.22 0.88
Total Income 116.47 108.27 105.63 72.67 52.89 51.57
EXPENDITURE :            
Raw Materials 74.41 69.10 66.58 42.51 31.07 31.22
Power and Fuel Cost 0.97 1.00 1.22 0.87 0.79 0.84
Employee Cost 7.95 6.55 5.90 4.92 4.57 4.75
Other Manufacturing Expenses 9.29 6.40 6.90 8.54 4.67 2.84
Selling and Administration Expenses 3.13 2.91 3.22 1.99 2.10 2.58
Miscellaneous Expenses 0.06 0.91 0.61 0.93 0.86 0.60
Employee Benefit Expenses 7.95 6.55 5.90 4.92 4.57 4.75
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 95.81 86.87 84.43 59.75 44.06 42.83
Operating Profit 20.66 21.40 21.20 12.93 8.84 8.73
Interest 0.37 0.27 0.55 0.29 0.43 0.31
Gross Profit 20.29 21.13 20.65 12.64 8.41 8.42
Depreciation 2.20 1.74 1.58 1.25 1.11 1.11
Profit Before Tax 18.09 19.39 19.07 11.39 7.30 7.31
Current Tax 4.66 5.26 5.11 3.06 2.15 2.16
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.35 0.02 -0.11 -0.02 0.14 -0.13
Reported Net Profit 13.79 14.11 14.07 8.36 5.01 5.29
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 13.79 14.11 14.07 8.36 5.01 5.29
Adjustment below Net Profit -0.75 -0.46 0.09 -4.90 -0.08 -0.06
P & L Balance brought forward 54.97 45.09 34.87 32.16 27.99 23.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.22 3.77 3.94 0.75 0.75 0.60
P & L Balance carried down 63.80 54.97 45.09 34.87 32.16 27.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 8.00 8.00 8.00 15.00 20.00 0.00
Dividend Per Share(Rs) 0.80 0.80 0.80 1.50 2.00 0.00
Earnings Per Share-Unit Curr 10.47 10.71 11.94 8.33 9.98 10.55
Earnings Per Share(Adj)-Unit Curr 10.47 10.71 11.94 8.33 4.99 5.28
Book Value 101.63 94.93 76.13 47.26 79.12 70.40
Book Value(Adj)-Unit Curr 101.63 94.93 76.13 47.26 39.56 35.20

Shareholding Pattern

  • Promoter Group

    56.12%

  • Public Share Holding

    43.88%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,392,485 56.12 7,392,285 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,392,485 56.12 7,392,285 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 409,517 3.11 409,117 37
Clearing Members 380 0.00 380 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 423,796 3.22 423,796 82
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 410,377 3.12 410,377 178
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,852,724 14.07 1,852,724 35
Individuals holding nominal share capital up to Rs. 1 lakh 2,508,372 19.04 2,356,572 7,622
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 8,400 0.06 8,400 1
Others 165,688 1.26 165,688 1
Sub Total 5,779,265 43.88 5,627,065 7,960
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,171,750 100.00 13,019,350 7,966

Company Background

Panchsheel Organics LtdPharmaceuticals - Indian - Bulk Drugs

  • Panchsheel Organics Ltd
  • BSE Code : 7121.0
  • ISIN : INE316G01019

  • Incorporation Year

    1989

  • Registered Office

    B-6 & B-7 Sector - C
    Industrial Estate Sanwer Road, Indore,
    Madhya Pradesh-452015

  • Telephone

    91-0731-22432 734

  • FAX

    91-0731-2721709

  • Chairman

    Mahendra Turakhia

  • Managing Director

  • Company Secretary

    Sonia Verma

  • Auditor

    Jayesh R Shah & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (India) Pvt
    Shiv Shakti Indust,
    Unit No 9 Lower Pare,7 B J R Boricha Marg
    Mumbai - Mumbai-400011

Panchsheel Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Panch.Organics 122.35 110.25 107.18 14.88 13.19
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77